FDA lowers age to 15 for OTC 'morning after' pill
This article was originally published in Scrip
The US FDA on 30 April lowered the age for nonprescription access to Teva's emergency contraceptive pill Plan B One-Step (1.5 mg levonorgestrel tablet) to teenagers as young as 15 years - although that move does not comply with a 5 April order from a US district court judge that called for the agency to make levonorgestrel-based morning after pills available without a prescription and without point-of-sale or age restrictions within 30 days.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.